XML 38 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Mar. 31, 2014
STOCKHOLDERS' EQUITY [Abstract]  
Schedule of Stock Option Activity
   
Nine months ended March 31, 2014 (Unaudited)
 
   
Number
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual Terms (in years)
   
Aggregate Intrinsic Value Price
 
Options outstanding at beginning of period
    1,958,156     $ 4.01              
Options exercised
    (15,000 )   $ 0.83              
Options forfeited
    (81,057 )   $ 11.59              
Options outstanding at end of the period
    1,862,099     $ 3.73       3.37     $ 1,461  
Options exercisable at the end of the period
    1,862,099     $ 3.73       3.37     $ 1,461  
Options vested
    1,862,099     $ 3.73       3.37     $ 1,461  
Schedule of Stock Option and Warrant Activity
   
Nine months ended March 31, 2014 (Unaudited)
 
   
Number
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual Terms (in years)
   
Aggregate Intrinsic Value Price
 
Options and warrants outstanding at beginning of period
    315,500     $ 4.40              
Options granted
    3,000     $ 0.00              
Options and warrants exercised
    (16,500 )   $ 1.74              
Options and warrants outstanding at end of the period
    302,000     $ 4.54       3.52     $ 535  
                                 
Options and warrants exercisable at the end of the period
    300,000     $ 4.54       3.45     $ 528  
                                 
Options and warrants vested and expected to vest
    302,000     $ 4.54       3.52     $ 535  
Options and warrants [Member]
 
Stockholders Equity Note [Line Items]  
Schedule of Stock-based Compensation Expenses
   
Nine months ended March 31,
   
Three months ended March 31,
 
   
2014
   
2013
   
2014
   
2013
 
Research and development expenses
  $ 7     $ -     $ 7     $ -  
General and administrative expenses
    -       24       -       3  
    $ 7     $ 24     $ 7     $ 3  
Restricted stock units [Member]
 
Stockholders Equity Note [Line Items]  
Schedule of Unvested Restricted Stock Units
   
Number
 
Unvested at the beginning of period
    1,660,525  
Granted
    1,224,908  
Forfeited
    (34,979 )
Vested
    (936,299 )
Unvested at the end of the period
    1,914,155  
Expected to vest after  March 31, 2014
    1,872,940  
Schedule of Stock-based Compensation Expenses
   
Nine months ended March 31,
   
Three months ended March 31,
 
   
2014
   
2013
   
2014
   
2013
 
Research and development expenses
  $ 656     $ 573     $ 442     $ 92  
General and administrative expenses
    3,299       1,299       1,196       270  
    $ 3,955     $ 1,872     $ 1,638     $ 362  
Consultant restricted stock units [Member]
 
Stockholders Equity Note [Line Items]  
Schedule of Unvested Restricted Stock Units
   
Number
 
Unvested at the beginning of period
    -  
Granted
    71,460  
Forfeited
    -  
Vested
    (40,300 )
Unvested at the end of the period
    31,160  
Expected to vest after March 31, 2014
    31,160  
Schedule of Stock-based Compensation Expenses
   
Nine months ended March 31,
   
Three months ended March 31,
 
   
2014
   
2013
   
2014
   
2013
 
Research and development expenses
  $ 59     $ 209     $ 42     $ 55  
General and administrative expenses
    157       278       157       -  
    $ 216     $ 487     $ 199     $ 55